
Michele Emdin
@micheleemdin
Cardiologist Researcher Teacher Husband Father Grandfather Son Grandson Proverbs 21:21
ID: 901361677328953344
26-08-2017 08:32:25
6,6K Tweet
979 Followers
1,1K Following




🎙️NEW #HeartFailure2025 #LBCT Interview 💫marianna fontana discusses findings from a study investigating #CRISPR gene editing in hereditary vs wild-type #ATTR #cardiomyopathy. 📽️Watch here👉 ow.ly/W5ij50VUwz7 #CardioEd #ESC_HFA #HeartFailure



Presented at #ATS2025: In the FIBRONEER-IPF phase 3 trial, nerandomilast slowed disease progression in patients with idiopathic pulmonary fibrosis as compared with placebo. Full trial results: nej.md/4mgWcIU American Thoracic Society (ATS)


🔴 Early Increase in Serum TTR by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy JACC Journals #Cardiology #CardioEd #Amyloidosis


Original Article: First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate (PREDMETH trial) nej.md/4kdaf0o Editorial: Methotrexate as Initial Therapy for Symptomatic Pulmonary Sarcoidosis? nej.md/4mhaHfW #ATS2025 | American Thoracic Society (ATS)


Great to see this paper out in JACC Journals Establishing the role of transthyretin (prealbumin) as a surrogate of treatment effect of transthyretin stabilizers in ATTR-CM, such as acoramidis in this particular paper jacc.org/doi/epdf/10.10… #CardioTwitter








Breaking News: Prothena Corporation has announced that the Phase 3 AFFIRM-AL clinical trial evaluating birtamimab in patients with Mayo Stage IV AL #amyloidosis failed to meet its primary endpoint. Learn more: arci.org/negative-affir…
